We studied spinal
analgesic and antiallodynic effects of
endomorphin-1 and
endomorphin-2 administered i.t. in comparison with Tyr-D-
Ala-Gly-MePhe-Gly-ol (
DAMGO) or
morphine, during acute, inflammatory and
neuropathic pain in rats chronically implanted with intrathecal cannulas.
Endomorphin-1 and
endomorphin-2 (2.5, 5, 10 microg i.t.) increased the tail-flick latency and, to the lesser extent, the paw pressure latency. The range of potencies in both those models of
acute pain was as follows:
DAMGO >
morphine =
endomorphin-1 >
endomorphin-2. In a model of inflammatory
pain, the number of
formalin-induced flinching episodes was decreased by
endomorphin-1. The effect of
endomorphin-2 was much less pronounced. Both
DAMGO and
morphine significantly inhibited the
pain-related behavior evoked by
formalin. In a
neuropathic pain model (sciatic nerve crushing in rats),
endomorphin-1 and -2 (5 microg i.t.) had a statistically significant effect on the tail-flick latency and on the cold-water tail flick latency.
Morphine, 5 microg, was found to be ineffective.
Endomorphin-1 and -2 (2.5 and 5 microg i.t.) dose-dependently antagonized
allodynia. Those effects of endomorphins were antagonized in acute (30 microg), inflammatory (30 microg) and
neuropathic pain models (60 microg) by
cyprodime, a selective
mu-opioid receptor antagonist. In conclusion, our results show a strong
analgesic action of endomorphins at the spinal cord level. The most interesting finding is a strong, stronger than in the case of
morphine, antiallodynic effect of endomorphins in rats subjected to sciatic nerve crushing, which suggests a possible use of these compounds in a very difficult
therapy of
neuropathic pain.